Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up

Abstract

Dydrogesterone did not appear to oppose the potentially beneficial effects of oestradiol on insulin or either low or high density lipoproteins, making the combination with 17 beta-oestradiol a potentially useful option for postmenopausal women particularly those at risk of cardiovascular disease or diabetes mellitus.